Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons

Nephrology Dialysis Transplantation

Volumn 19, Issue 7, 2004, Pages 1752-1760

  Boulday, Gwénola ^a   Ashton Chess, Joanna ^a   Bernard, Pierre ^a   Karam, Georges ^a   Vié, Henri ^a   Moreau, Anne ^b   Minault, David ^a   Lorré, Katrien ^c   Soulillou, Jean Paul ^a   Blancho, Gilles ^a  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c INNOGENETICS   (Belgium)

Author keywords

Anti B7 antibodies; Baboons; Co stimulation; Rapamycin; Renal allotransplantation

Indexed keywords

ANTIBODY; B7 ANTIGEN; CD28 ANTIGEN; CYCLOSPORIN A; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7; MONOCLONAL ANTIBODY CD80; MONOCLONAL ANTIBODY CD86; RAPAMYCIN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ALLOIMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CAUSE OF DEATH; CONTROLLED STUDY; DRUG HALF LIFE; GRAFT SURVIVAL; IMMUNOSTIMULATION; IN VITRO STUDY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG EMBOLISM; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; MONOCYTE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PAPIO ANUBIS; SIROLIMUS; TIME FACTORS;

EID: 3242686859     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh126     Document Type: Article

References (22)

1. Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: a review. Crit Rev Immunol 1998; 18: 389-418
2. Sebille F, Vanhove B, Soulillou JP. Mechanisms of tolerance induction: blockade of co-stimulation. Plalos Trans R Soc Lond B Biol Sci 2001; 356: 649-657
3. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002; 14: 592
4. Linsley PS, Brady W, Urnes M et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561-569
5. Pearson TC, Alexander DZ, Corbascio M et al. Analysis of the B7 costimulatory pathway in allograft rejection. Transplantation 1997; 63: 1463-1469
6. Woodward JE, Bayer AL, Chavin KD, Blue ML, Baliga P. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade. Transplantation 1998; 66: 14-20
7. Guillot C, Mathieu P, Coathalem H et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 2000; 164: 5258-5268
8. Pearson TC, Alexander DZ, Winn KJ et al. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701-1706
9. Jonker M, Ossevoort, M, Vierboom M. Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models. Transplantation 2002; 73 [1 Suppl]: S23-S26
10. Ossevoort MA, Ringers J, Kuhn EM et al. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway. Transplantation 1999; 68: 1010-1018
11. Kirk AD, Tadaki DK, Celniker A et al. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 2001; 72: 377-384
12. Hausen B, Klupp J, Christians U et al. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys. Transplantation 2001; 72: 1128-1137
13. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438
14. Li Y, Zheng XX, Li XC, Zand MS, Strom TB. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation 1998; 66: 1387-1388
15. Wells AD, Li XC, Li Y et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nature Med 1999; 5: 1303-1307
16. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311-1318
17. Qi S, Xu D, Peng J et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. Transplantation 2000; 69: 1275-1283
18. Birsan T, Hausen B, Higgins JP et al. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Transplantation 2003; 75: 2106-2113
19. Gagne K, Brouard S, Giral M et al. Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts. J Immunol 2000; 164: 1553-1563
20. Durham MM, Bingaman AW, Adams AB et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000; 165: 1-4
21. Kawai T, Sachs DH, Cosimi AB. Tolerance to vascularized organ allografts in large-animal models. Curr Opin Immunol 1999; 11: 516-520
22. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349-1356